230 related articles for article (PubMed ID: 35021971)
1. Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications.
Yang L; Zhang Z; Wang D; Jiang Y; Liu Y
Curr Drug Targets; 2022; 23(7):692-710. PubMed ID: 35021971
[TBL] [Abstract][Full Text] [Related]
2. Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors.
Melick CH; Jewell JL
Biochem J; 2020 May; 477(10):1847-1863. PubMed ID: 32347294
[TBL] [Abstract][Full Text] [Related]
3. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Yoon MS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
[TBL] [Abstract][Full Text] [Related]
4. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
5. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD
Cells; 2024 Feb; 13(5):. PubMed ID: 38474373
[TBL] [Abstract][Full Text] [Related]
6. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma.
Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD
Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736
[TBL] [Abstract][Full Text] [Related]
7. The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.
Suhara T; Baba Y; Shimada BK; Higa JK; Matsui T
Curr Diab Rep; 2017 Jun; 17(6):38. PubMed ID: 28434143
[TBL] [Abstract][Full Text] [Related]
8. Growing knowledge of the mTOR signaling network.
Huang K; Fingar DC
Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279
[TBL] [Abstract][Full Text] [Related]
9. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Weinberg MA
Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
[TBL] [Abstract][Full Text] [Related]
11. mTORC2: a multifaceted regulator of autophagy.
Sun Y; Wang H; Qu T; Luo J; An P; Ren F; Luo Y; Li Y
Cell Commun Signal; 2023 Jan; 21(1):4. PubMed ID: 36604720
[TBL] [Abstract][Full Text] [Related]
12. Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.
Ghomlaghi M; Yang G; Shin SY; James DE; Nguyen LK
PLoS Comput Biol; 2021 Sep; 17(9):e1008513. PubMed ID: 34529665
[TBL] [Abstract][Full Text] [Related]
13. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
14. The complex network of mTOR signalling in the heart.
Sciarretta S; Forte M; Frati G; Sadoshima J
Cardiovasc Res; 2022 Jan; 118(2):424-439. PubMed ID: 33512477
[TBL] [Abstract][Full Text] [Related]
15. Dynamic modeling of signal transduction by mTOR complexes in cancer.
Dorvash M; Farahmandnia M; Mosaddeghi P; Farahmandnejad M; Saber H; Khorraminejad-Shirazi M; Azadi A; Tavassoly I
J Theor Biol; 2019 Dec; 483():109992. PubMed ID: 31493485
[TBL] [Abstract][Full Text] [Related]
16. mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function.
Yuan T; Lupse B; Maedler K; Ardestani A
J Mol Biol; 2018 Mar; 430(7):904-918. PubMed ID: 29481838
[TBL] [Abstract][Full Text] [Related]
17. Control of B lymphocyte development and functions by the mTOR signaling pathways.
Iwata TN; Ramírez-Komo JA; Park H; Iritani BM
Cytokine Growth Factor Rev; 2017 Jun; 35():47-62. PubMed ID: 28583723
[TBL] [Abstract][Full Text] [Related]
18. Using
Frappaolo A; Giansanti MG
Cells; 2023 Nov; 12(22):. PubMed ID: 37998357
[TBL] [Abstract][Full Text] [Related]
19. Regulation and metabolic functions of mTORC1 and mTORC2.
Szwed A; Kim E; Jacinto E
Physiol Rev; 2021 Jul; 101(3):1371-1426. PubMed ID: 33599151
[TBL] [Abstract][Full Text] [Related]
20. Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes.
Chen J; Liu K; Liu Y; Wang X; Zhang Z
Exp Dermatol; 2019 Mar; 28(3):270-275. PubMed ID: 30650200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
